UDK: 616.127–005.8–085.31

Status of patients with acute myocardial infarction after asparcam-L, panangin and potassium and magnesium asparaginate therary

V. I. Petrov, P. A. Bakumov, A. V. Glinskaya, S. P. Voronin

Кафедра клинической фармакологии и интенсивной терапии с курсами клинической фармакологии, аллергологии и иммунологии ФУВ

Abstract

122 patients with acute myocardial infarction participated in the study. They received standard therapy and Asparcam-L or Panangin, or potassium and magnesium asparaginate. Efficiency and safety was studied with ECG, echocardiogram, quality of life questionnaires and laboratory methods. Asparcam-L presented good tolerance, safety and efficiency during acute myocardial infarction treatment, as well as a better prognosis.

Keywords

acute myocardial infarction, аsparcam-L, hypomagnesaemia, hypokalemia, quality of life

Contacts

Петров Владимир Иванович – Заслуженный деятель науки РФ, Заслуженный врач РФ, Академик РАМН, д.м.н., профессор, зав. кафедрой клинической фармакологии и интенсивной терапии с курсами клинической фармакологии ФУВ, клинической аллергологии ФУВ, восстановите